ArticleCancer immunology, immunotherapy : CII2013

Concomitant combination of active immunotherapy and carboplatin- or paclitaxel-based chemotherapy improves anti-tumor response.

Y Diaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.